Liothyronine sodium (Mylan Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Liothyronine sodium drug offered from Mylan Pharmaceuticals Inc.. This l-Triiodothyronine [EPC],Triiodothyronine [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Mylan Pharmaceuticals Inc. |
NON-PROPRIETARY NAME: | Liothyronine sodium |
SUBSTANCE NAME: | LIOTHYRONINE SODIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | l-Triiodothyronine [EPC],Triiodothyronine [Chemical/Ingredient] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2016-10-03 |
END MARKETING DATE: | 0000-00-00 |
Liothyronine sodium HUMAN PRESCRIPTION DRUG Details:
Item Description | Liothyronine sodium from Mylan Pharmaceuticals Inc. |
LABELER NAME: | Mylan Pharmaceuticals Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5(ug/1) |
START MARKETING DATE: | 2016-10-03 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0378-3611_7f56aaf9-505a-48c9-bffc-c054b261d82f |
PRODUCT NDC: | 0378-3611 |
APPLICATION NUMBER: | ANDA090326 |
Other LIOTHYRONINE SODIUM Pharmaceutical Manufacturers / Labelers: